| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $106.0M | +38.9% |
| R&D Expense | $137.0M | +1.8% |
| SG&A Expense | $61.5M | +0.0% |
| Operating Income | -$92.5M | +32.5% |
| Pre-tax Income | -$79.8M | +31.6% |
| Income Tax | $1.4M | -77.4% |
| Net Income | -$81.1M | +33.9% |
| EPS (Basic) | -$1.08 | +33.3% |
| EPS (Diluted) | -$1.08 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.2M | -37.7% |
| Accounts Receivable | $4.6M | -91.7% |
| Current Assets | $248.8M | -17.2% |
| Total Assets | $346.5M | -25.2% |
| Current Liabilities | $42.3M | -52.1% |
| Total Liabilities | $78.0M | -37.2% |
| Stockholders' Equity | $268.5M | -20.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.0M | +70.0% |
| Capital Expenditures | $1.5M | -23.6% |
| Investing Cash Flow | $26.7M | -31.2% |
| Financing Cash Flow | -$18.6M | +9.3% |
| Free Cash Flow | -$34.5M | +69.2% |
| +33.3% |